当前位置:首页 - 行情中心 - 海辰药业(300584) - 财务分析 - 利润表

海辰药业

(300584)

  

流通市值:14.74亿  总市值:21.54亿
流通股本:8211.86万   总股本:1.20亿

利润表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、营业总收入377,948,363.64261,547,849.93117,201,090.18526,465,340.15
营业收入377,948,363.64261,547,849.93117,201,090.18526,465,340.15
二、营业总成本350,261,784.04237,466,136.47102,187,516.82490,310,328.95
营业成本69,138,496.4945,231,823.120,805,227.91130,017,384.06
税金及附加8,385,143.35,693,449.552,650,224.859,768,357
销售费用180,025,425.29123,271,654.4559,708,037.04268,705,726.52
管理费用55,857,864.1436,736,625.8914,295,714.1157,288,113.53
研发费用31,900,346.6123,377,177.133,013,143.8218,217,376.43
财务费用4,954,508.23,155,406.361,715,169.096,313,371.41
其中:利息费用6,620,282.553,810,890.651,910,288.957,252,719.61
其中:利息收入854,063.94658,395.67205,934.851,015,427.39
加:公允价值变动收益62,369.7258,520.67-927,857.26
加:投资收益---1,247.21
资产处置收益343,411.59343,411.591,431.87-952,179.05
资产减值损失(新)-6,188,489.8-4,603,144.71-1,823,474.05-3,772,316.96
信用减值损失(新)327,989.18123,274.57823,810.31-4,525,841.99
其他收益1,856,133.521,171,918.5598,846.362,267,395.11
营业利润平衡项目0000
四、营业利润24,087,993.8121,175,694.0814,614,187.8530,101,172.78
加:营业外收入231,258.36240,384.922,671172,816.27
减:营业外支出1,356,920.681,120,320.071,043,209.81,497,998.33
利润总额平衡项目0000
五、利润总额22,962,331.4920,295,758.9113,593,649.0528,775,990.72
减:所得税费用539,899.03820,832.391,379,835.16-3,348,290.48
六、净利润22,422,432.4619,474,926.5212,213,813.8932,124,281.2
持续经营净利润22,422,432.4619,474,926.5212,213,813.8932,124,281.2
归属于母公司股东的净利润22,422,432.4619,474,926.5212,213,813.8932,448,867.56
少数股东损益----324,586.36
(一)基本每股收益0.190.160.10.27
(二)稀释每股收益0.190.160.10.27
九、综合收益总额22,422,432.4619,474,926.5212,213,813.8932,124,281.2
归属于母公司股东的综合收益总额22,422,432.4619,474,926.5212,213,813.8932,448,867.56
归属于少数股东的综合收益总额----324,586.36
公告日期2023-10-272023-08-232023-04-252023-04-25
审计意见(境内)标准无保留意见
TOP↑